Article Type
Article
Changed
Tue, 09/25/2018 - 09:42
Display Headline
Helicobacter pylori: Why it still matters in 2005
Author(s)
M. Brian Fennerty, MD
Article PDF
content_72_Suppl_2_SI-1.pdf
Author and Disclosure Information

M. Brian Fennerty, MD
Division of Gastroenterology, Oregon Health & Science University, Portland, OR

Dr. Fennerty has served as a consultant to AstraZeneca Pharmaceuticals, Eisai, Meridian Bioscience, Santarus, and TAP Pharmaceutical Products.

 

Publications
Cleveland Clinic Journal of Medicine
Page Number
S1-S7
Author(s)
M. Brian Fennerty, MD
Author(s)
M. Brian Fennerty, MD
Author and Disclosure Information

M. Brian Fennerty, MD
Division of Gastroenterology, Oregon Health & Science University, Portland, OR

Dr. Fennerty has served as a consultant to AstraZeneca Pharmaceuticals, Eisai, Meridian Bioscience, Santarus, and TAP Pharmaceutical Products.

 

Author and Disclosure Information

M. Brian Fennerty, MD
Division of Gastroenterology, Oregon Health & Science University, Portland, OR

Dr. Fennerty has served as a consultant to AstraZeneca Pharmaceuticals, Eisai, Meridian Bioscience, Santarus, and TAP Pharmaceutical Products.

 

Article PDF
content_72_Suppl_2_SI-1.pdf
Article PDF
content_72_Suppl_2_SI-1.pdf
Related Articles
How to test for Helicobacter pylori in 2005
Pitfalls, pearls, and practicalities in the diagnosis of Helicobacter pylori infection
Page Number
S1-S7
Page Number
S1-S7
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Article Type
Article
Display Headline
Helicobacter pylori: Why it still matters in 2005
Display Headline
Helicobacter pylori: Why it still matters in 2005
Citation Override
Cleveland Clinic Journal of Medicine 2005 May;72(suppl 2):S1-S7
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media